BAYER AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.96 EUR | +0.92% |
|
+3.34% | -13.90% |
| 05-10 | Strong TV ratings for RTL for Leverkusen's run to the final | DP |
| 05-09 | War upends Ukraine's economy in a shift that may be permanent | RE |
| Sales 2024 * | 47.09B 50.71B 4,052B | Sales 2025 * | 47.95B 51.64B 4,126B | Capitalization | 28.45B 30.63B 2,448B |
|---|---|---|---|---|---|
| Net income 2024 * | 2.08B 2.24B 179B | Net income 2025 * | 3.17B 3.41B 273B | EV / Sales 2024 * | 1.31 x |
| Net Debt 2024 * | 33.1B 35.65B 2,848B | Net Debt 2025 * | 29.67B 31.96B 2,553B | EV / Sales 2025 * | 1.21 x |
| P/E ratio 2024 * |
13.2
x | P/E ratio 2025 * |
8.91
x | Employees | 96,931 |
| Yield 2024 * |
0.38% | Yield 2025 * |
0.8% | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Bayer AG
More press releases
| 1 day | +0.92% | ||
| 1 week | +3.34% | ||
| Current month | +5.87% | ||
| 1 month | +5.00% | ||
| 3 months | +2.22% | ||
| 6 months | -27.89% | ||
| Current year | -13.90% |
1 week
27.93
29.27
1 month
25.6129.27
Current year
24.9636.09
1 year
24.9656.50
3 years
24.9667.99
5 years
24.9678.34
10 years
24.96146.45
| Managers | Title | Age | Since |
|---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 57 | 31/03/23 |
| Director of Finance/CFO | 55 | 25/04/18 | |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 31/03/20 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Colleen Goggins
BRD | Director/Board Member | 68 | 31/03/17 |
Alberto Weisser
BRD | Director/Board Member | 67 | 31/03/21 |
Paul Achleitner
BRD | Director/Board Member | 67 | 31/03/02 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 9.77% | 70 M€ | -.--% | - | |
| 5.71% | 2 M€ | +13.56% | - | |
| 4.28% | 962 M€ | -.--% | - | |
| 4.10% | 0 M€ | 0.00% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 28.96 | +0.92% | 3,655,535 |
| 09/05/24 | 28.69 | +0.76% | 1,997,631 |
| 08/05/24 | 28.48 | -0.04% | 2,244,692 |
| 07/05/24 | 28.48 | +1.51% | 3,346,510 |
| 06/05/24 | 28.06 | +0.14% | 1,803,823 |
Delayed Quote Xetra, May 10, 2024 at 04:37 pm
More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
Pharmaceuticals
Calendar
14/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
28.96
EUR
Average target price
36.9
EUR
Spread / Average Target
+27.46%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -13.90% | 30.37B | |
| +30.38% | 695B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 330B | |
| +3.73% | 283B | |
| +16.70% | 239B | |
| +8.78% | 204B | |
| -7.93% | 198B | |
| +7.68% | 168B |
- Stock Market
- Equities
- BAYN Stock
